Cardiovascular Ultrasound Market Report 2026

The cardiovascular ultrasound market size has grown strongly in recent years. It will grow from $2.58 billion in 2025 to $2.76 billion in 2026 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to rising prevalence of cardiovascular diseases, expansion of hospital diagnostic infrastructure, increased use of non-invasive diagnostic techniques, growing awareness of early cardiac diagnosis, technological advancements in ultrasound imaging.

The cardiovascular ultrasound market size is expected to see strong growth in the next few years. It will grow to $3.79 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing demand for early disease detection, rising adoption of portable diagnostic devices, expansion of telecardiology services, growing investments in advanced imaging technologies, increasing focus on precision cardiology diagnostics. Major trends in the forecast period include increasing adoption of AI-assisted image interpretation, rising use of portable and point-of-care ultrasound systems, growing demand for high-resolution cardiac imaging, expansion of doppler-based diagnostic applications, enhanced focus on workflow integration and automation.

The rising prevalence of cardiovascular disease is anticipated to drive the growth of the cardiovascular ultrasound market in the coming years. Cardiovascular disease (CVD) encompasses a group of disorders affecting the heart or blood vessels. Cardiovascular ultrasound, also referred to as echocardiography, is an essential and non-invasive imaging method that plays a key role in diagnosing, evaluating, and managing cardiovascular diseases (CVD). For example, in August 2025, the National Institutes of Health, a US-based government agency, reported that between 2025 and 2050, the prevalence of cardiovascular disease is expected to increase by 90%, mortality by 73%, and DALYs by 55%, with deaths rising from 20.5 million to 35.6 million. Consequently, the growing prevalence of cardiovascular disease is fueling the expansion of the cardiovascular ultrasound market.

Major companies operating in the cardiovascular ultrasound market are concentrating on developing new handheld ultrasound imaging systems, such as Vscan Air SL, to deliver reliable services to customers. The Vscan Air SL handheld ultrasound imaging system is a portable device that utilizes ultrasound waves to generate images of the body's internal structures when connected to a tablet or smartphone. For example, in August 2023, GE HealthCare Technologies Inc., a US-based provider of medical technology, pharmaceutical diagnostics, and digital solutions, launched Vscan Air SL. This portable, wireless ultrasound imaging system can be employed for rapid cardiac and vascular assessments to accelerate diagnosis and treatment decisions. The integration of SignalMax and XDclear, imaging performance technologies, is a distinctive feature of this system that enables high penetration, resolution, and sensitivity levels using single crystal transducer technology. The new SL version includes a sector-phased array transducer for quick cardiac examinations. Clinicians can carry Vscan Air to every patient thanks to the Vscan Air app, which is available on Android and iOS smartphones.

In March 2025, Boston Scientific Corporation, a US-based provider of interventional medical devices and cardiovascular therapy systems, acquired SoniVie Ltd. for an undisclosed amount. Through this acquisition, Boston Scientific intends to integrate SoniVie’s TIVUS™ intravascular ultrasound (IVUS) technology into its interventional portfolio to provide a minimally invasive, ultrasound-based therapy for hypertension via renal artery denervation. SoniVie Ltd. is a UK-based medical device company developing the TIVUS system, a catheter-based intravascular ultrasound platform that delivers ultrasound energy to renal artery nerves to lower blood pressure.

Major companies operating in the cardiovascular ultrasound market are GE HealthCare Technologies Inc., Koninklijke Philips N.V., Siemens Healthineers AG, Hitachi Medical Corp., Samsung Medison Co. Ltd., Mindray Medical International Limited, Chison Wuxi Xiangsheng Medical Technology Co. Ltd., Fujifilm Sonosite Inc., Canon Medical Systems Corporation, Clarius Mobile Health, Dawei Medical (Jiangsu) Corp. Ltd., Esaote SpA, Fujifilm Holdings Corporation, Shenzhen Lanmage Medical Technology Co. Ltd., Leltek Inc., Telemed Ultrasound Medical Systems, Viatom Technology Co, Wuhan Zoncare Bio-medical Electronics Co. Ltd., Shenzhen Bestman Instrument Co. Ltd., Biim Ultrasound AS, Shenzhen WELLD Medical Electronics Co. Ltd.

North America was the largest region in the cardiovascular ultrasound market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular ultrasound market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiovascular ultrasound market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the cardiovascular ultrasound market by increasing costs of imported imaging components, transducers, semiconductors, and advanced display systems used in echocardiography equipment. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported high-end imaging systems, while Asia-Pacific faces pricing pressure on manufacturing and exports. These tariffs are raising capital equipment costs and slowing replacement cycles for healthcare providers. However, they are also encouraging localized manufacturing, regional supplier partnerships, and innovation in cost-optimized ultrasound platforms.

The cardiovascular ultrasound market research report is one of a series of new reports that provides cardiovascular ultrasound market statistics, including cardiovascular ultrasound industry global market size, regional shares, competitors with a cardiovascular ultrasound market share, detailed cardiovascular ultrasound market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular ultrasound industry. This cardiovascular ultrasound market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cardiovascular ultrasound is a noninvasive diagnostic technique that employs high-frequency sound waves to create images of the heart and its surrounding blood vessels. This imaging method enables healthcare professionals to examine the heart's chambers, valves, walls, and blood vessels, providing detailed information about its structure and function.

The primary types of cardiovascular ultrasounds include transthoracic echocardiography, transesophageal echocardiography, fetal echocardiography, and others. Transthoracic echocardiography (TTE) is a non-invasive diagnostic procedure that uses ultrasonic waves to generate images of the heart and its associated blood vessels. The technologies involved include 2D, 3D or 4D, and Doppler, with display options such as black and white (b/w) or color. The end users include hospitals, diagnostic centers, ambulatory care centers, and others.

The cardiovascular ultrasound market consists of revenues earned by entities by providing services such as diagnosis, consultation, telemedicine services, and vascular imaging services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiovascular ultrasound market also includes sales of cardiac ultrasound machines, ultrasound probes, and Holter monitoring systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.